title: Biosimilars in the Caribbean--key considerations.
authors.forename: S Dawkins
authors.initials: SD
authors.lastname: Cox
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D017691:Caribbean Region; D003362:Cost-Benefit Analysis / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence; D057915:Drug Substitution / Q000191:economics; D016568:Drugs, Generic / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
chemical_list: D059451:Biosimilar Pharmaceuticals; D016568:Drugs, Generic